TD Cowen Cuts Microsoft Price Target to $625, Highlights Azure Capacity Limits

MSFTMSFT

TD Cowen maintained a Buy rating on Microsoft but cut its price target to $625 from $655 ahead of its Jan. 28 fiscal Q2 report. Analyst Derrick Wood cited robust GPU and CPU demand for AI workloads and expects a two-point boost to Azure growth, limited by capacity constraints.

1. Burry Warns of Unstoppable AI Bubble

Scion Asset Management founder Michael Burry cautioned investors that the artificial intelligence boom has become “too big to save,” arguing that even aggressive government support cannot prevent a sharp downturn. He pointed to OpenAI’s most recent quarterly results—reporting a $540 million operating loss on research and development—and warned that mounting losses at the $30 billion–valued startup signal fragile fundamentals. Burry expects a sudden “unwind” as venture funding and corporate commitments falter, creating ripple effects across technology portfolios heavily exposed to AI hype.

2. F1 Sponsorship Deal Underscores Brand Strength

Microsoft, the $3.4 trillion computing giant, will be unveiled this week as a major sponsor of the Mercedes Formula One team when the 2026 livery is revealed. Industry estimates place the multi-year agreement at approximately $60 million per season, ranking it among F1’s top five individual team sponsorships. The deal follows a record £4.6 billion valuation of the Brackley-based outfit and positions Microsoft alongside peers such as Google, which partners with reigning champions McLaren. For investors, the tie-in highlights Microsoft’s continued emphasis on high-visibility marketing and brand alignment with cutting-edge technology.

3. Advancing AI in Healthcare Through BMS Partnership

In a joint venture with Bristol Myers Squibb, Microsoft plans to deploy FDA-cleared radiology AI algorithms via its Precision Imaging Network, now used in over 80% of U.S. hospitals. The platform will analyze X-ray and CT scans to flag potential lung nodules—critical in the fight against the roughly 227,000 new U.S. lung cancer diagnoses and 125,000 annual deaths. By integrating workflow tools that track patients through community clinics and rural hospitals, the collaboration aims to reduce the 50% rate of incidental findings that go unmonitored, potentially improving early detection and treatment pathways for medically underserved populations.

4. Wall Street Remains Bullish Despite Near-Term Caution

TD Cowen analyst Derrick Wood reaffirmed a Buy rating on Microsoft ahead of its January 28 earnings release, trimming his 12-month price target to $625 from $655 to reflect capacity constraints in Azure infrastructure. Wood’s channel checks indicate GPU and CPU demand for AI workloads remains robust, and he sees potential for Azure’s constant-currency growth to exceed consensus by two percentage points once supply bottlenecks ease. While near-term revenue acceleration may be muted, the firm expects cloud revenue—up 40% year-over-year—and enterprise AI services to drive a re-acceleration in the back half of 2026.

Sources

FFN22
+5 more